This lecture reviews the history of coronary heart disease prevention and discusses potential next steps in drug therapies for primary prevention.
Supports integrated risk-factor and treatment strategies in CHD prevention; leaves open next drug targets for primary prevention.
Blackburn entitled his introduction to the first Ancel Keys lecture "Ancel Keys, pioneer" and summarized Keys' astonishing array of work in nutrition and physiology, methods, and prevention, including the diet-heart hypothesis and efforts to bridge biology, preventive medicine, and public health. 2 As a result of his work and the work of many others over the last 50 years, the mortality rate from coronary heart disease (CHD) declined by about 50% between 1980 and 2000, a decline attributable in part to changes in medical treatments after coronary events and in part to changes in levels of risk factors in the population. In this lecture, as an admiring follower and a northwest settler, I consider some potential next steps in CHD prevention.
No takes yet. Share an insight, caveat, or question.
Bruce M. Psaty (2010) conducted a review in Coronary heart disease. Drug therapies for primary prevention was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: